Microsoft Word - RadBio_Programme_ParisSept2017_verAug31

1582-1583 / 2063

Rationale for combination with anti-PD-L1 Ab
Radio(chemo)-immunotherapy: works with various solid tumors
Golden et al., Lancet Oncology, 2015 and Frey, Gaipl, Lancet Oncology,